Pacira | PCRX - Ebit





Ebit تغيير تاريخ
Astellas Pharma JPY 134.54B 30.13B 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Cara Therapeutics USD -2.39M 3.16M 2025-03
Coherus Biosciences USD -39.08M 3.65M 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
J&J USD 5.11B 2.3B 2025-12
Ligand Pharmaceuticals USD 158.89M 115.32M 2025-09
Nektar Therapeutics USD -34.34M 3.68M 2024-09
Novo Nordisk DKK 32.38B 1.7B 2025-12
Omeros USD -48.15M 7.25M 2023-09
Pacira USD 3.19M 9.96M 2025-12
Perrigo USD 84.4M 9M 2025-12
Pfizer USD 4.65B 71M 2025-12
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
Teva Pharmaceutical Industries USD 577M 491M 2025-12
Xeris Pharmaceuticals USD 16.77M 8.88M 2025-12
Xoma USD -10.08M 4.4M 2024-06
Zoetis USD 835M 140M 2025-12